Skip to content

Hyperoxemia and Ventilator-associated Pneumonia

Impact of Hyperoxemia on Incidence of Ventilator-associated Pneumonia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03434821
Acronym
SOH-VAP
Enrollment
534
Registered
2018-02-15
Start date
2018-03-15
Completion date
2022-04-30
Last updated
2022-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mechanical Ventilation

Keywords

Hyperoxemia, ventilator-associated, pneumonia, critical illness

Brief summary

The aim of this prospective cohort single-center observational study is to determine the impact of hyperoxemia on ventilator-associated pneumonia (VAP) occurrence. * SpO2 will be continuously recorded in order to determine the percentage of time spent with hyperoxemia. * Patients with VAP will be prospectively identified. * Patient characteristics and risk factors for VAP will be prospectively collected. * Oxidant stress will be prospectively investigated in study patients: glutathion peroxidase (GPX), plasmatic superoxyde dismutase (SOD), total plasmatic antioxidant status (SAT) and urinary 8-isoprostanes will be performed at ICU admission, once a week, and at VAP occurrence. Patients with VAP will be compared with those with no VAP

Interventions

None listed

Sponsors

University Hospital, Lille
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients admitted to the ICU * Expected duration of mechanical ventilation \> 48h * Signed informed consent * Social insurance

Exclusion criteria

* Pregnancy or breast feeding * No informed consent * Hyperbaric oxygen treatment * Prisoners and patients under guardianship

Design outcomes

Primary

MeasureTime frameDescription
VAP occurrence28 days after ICU admissionhyperoxemia at ICU admission (PaO2 \>120 mmHg)

Secondary

MeasureTime frameDescription
percentage of time spent with hyperoxemia during ICU stay, and the presence of acute lung injury28 days after ICU admissionthe percentage of time spent with hyperoxemia during ICU stay will be calculated as mentioned above (outcome 2). This percentage will be compared between patient with ALI and those with no ALI
percentage of time spent with hyperoxemia during ICU stay28 days after ICU admissionhyperoxemia is defined as peripheral O2 saturation (SaO2)\>98%, SaO2 will be measured every 30 seconds, and the percentage of time spent with hyperoxemia will be calculated per day.
relationship between hyperoxemia at ICU admission and the presence of acute lung injury (ALI)28 days after ICU admissionthe presence of hyperoxemia at ICU admission will be determined using blood gazes (arterial PaO2\>120 mmHg). The percentage of patients with hyperoxemia will be compared between patients with Ali, and those with no ALI

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 15, 2026